Molecular profiling reveals low- and high-grade forms of primary melanoma.
about
Host kinin B1 receptor plays a protective role against melanoma progression.A protein deep sequencing evaluation of metastatic melanoma tissuesCorrelation of histopathologic characteristics to protein expression and function in malignant melanoma.Melanoma: clinical features and genomic insights.The clinicopathological and gene expression patterns associated with ulceration of primary melanomaLoss of CITED1, an MITF regulator, drives a phenotype switch in vitro and can predict clinical outcome in primary melanoma tumours.Molecular and genetic diversity in the metastatic process of melanomaCo-clinical assessment identifies patterns of BRAF inhibitor resistance in melanomaIndependent replication of a melanoma subtype gene signature and evaluation of its prognostic value and biological correlates in a population cohort.Molecular stratification of metastatic melanoma using gene expression profiling: Prediction of survival outcome and benefit from molecular targeted therapy.DNA methylation subgroups in melanoma are associated with proliferative and immunological processesRevisiting determinants of prognosis in cutaneous melanoma.Establishing a Southern Swedish Malignant Melanoma OMICS and biobank clinical capabilitySecretome from senescent melanoma engages the STAT3 pathway to favor reprogramming of naive melanoma towards a tumor-initiating cell phenotype.Mapping heterogeneity in patient-derived melanoma cultures by single-cell RNA-seq.Molecular networks in melanoma invasion and metastasis.Molecular markers in melanoma.Dissection of immune gene networks in primary melanoma tumors critical for antitumor surveillance of patients with stage II-III resectable disease.Genetic progression of malignant melanoma.Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF Regulation.Biomarkers in melanoma.WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells.Mechanisms and prevention of UV-induced melanoma.The therapeutic promise of disrupting the PD-1/PD-L1 immune checkpoint in cancer: unleashing the CD8 T cell mediated anti-tumor activity results in significant, unprecedented clinical efficacy in various solid tumors.Biological determinants of bladder cancer gene expression subtypes.BAP1 has a survival role in cutaneous melanoma.Identification of a gene signature for discriminating metastatic from primary melanoma using a molecular interaction network approach.Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma.Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells.High MITF Expression is Associated with Super-enhancers and Suppressed by CDK7 Inhibition in Melanoma.Immune profiling of melanoma tumors reflecting aggressiveness in a preclinical model.Pseudotime Dynamics in Melanoma Single-Cell Transcriptomes Reveals Different Mechanisms of Tumor Progression.β-Catenin-mediated immune evasion pathway frequently operates in primary cutaneous melanomas.Molecular pathology of cutaneous melanoma
P2860
Q27340170-8AE7F9B6-4D6F-42E9-BD0F-01A1D051BA07Q28546229-F209D4BB-2B47-4064-87FA-3706393D0CADQ33605879-B0FADAC6-E637-4D0F-A8FF-AE8D008FDDBBQ34083191-2D3FBAD8-753C-47C5-A49A-55807E486968Q34772146-22C9DB76-86CB-48D2-90BD-C6FCB8C72B3FQ35145922-FAC09BDE-5A01-4C33-9F70-8839DBA473C7Q35177775-C7FB911B-D313-437C-8119-F3F4C363FB0FQ35408594-80C8B79D-2E05-4E26-8ED2-B628FBAE3F8BQ35793900-12608348-25AC-4756-A0F3-2BF30D350D8FQ35828560-277608E5-E5E0-4AE9-B5F7-817534AC36EBQ35834765-0D7185F0-DE59-4E95-9C76-B522F6F363EDQ36338825-81BA7C7C-23FC-4E35-B4F7-4155A75B9B66Q36689829-7FBE743E-D68D-474E-830D-1FF397F76A1EQ37589120-DC4E83B8-7ED5-4783-A57F-F8B33623F777Q37702372-FAFD0F31-3B2A-443B-A729-08004932DF27Q38104416-A206A728-F261-429B-8890-F3F7528B0891Q38118361-79B6EBF5-410B-4F67-8573-CC71FB3D262DQ38441450-B1EE0E38-1A0C-4D28-B32A-ECDB47A914EAQ38771870-D3FCE34D-4F9A-4E55-A822-79FA196F9E50Q38906998-4B9D05CB-B9DE-4783-82F8-E5D3F53FC12EQ38911167-5E718438-5150-4FB4-90EA-B25834ABB760Q39001226-B3D9DD09-361E-4EB0-A394-0D19EBAB3411Q39432336-CB50F94D-B0B0-4728-954B-21D066A49A67Q39828989-DFD04875-041A-46D9-80E4-331754285850Q40861069-70CEBDF7-3574-4B99-A5B6-9B02A311FBDCQ43194421-69E509D1-B14B-45DD-8619-CC5A3F740ECBQ45943042-E6DD2B02-E1D1-4755-AAA0-E40BF0191ED1Q47157659-42087BC1-FE9A-47C5-BE96-69AA1C3CD5BFQ47227422-56E5EA19-BFFA-4719-A6C3-BD946AA34EE2Q48510616-3E808BC9-B0FD-45F8-B4CB-3A9482E97365Q51795679-507DEB3C-6E1C-40A8-83A2-10BFB8A1A149Q52722046-E908FFB5-1F5F-468E-B34F-5CD6378D0C45Q52801913-309ABB70-9BB1-4176-99E7-334EA07E4ADDQ56428911-AF3002B0-7F03-40AA-9D45-5918719EAD6B
P2860
Molecular profiling reveals low- and high-grade forms of primary melanoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Molecular profiling reveals low- and high-grade forms of primary melanoma.
@ast
Molecular profiling reveals low- and high-grade forms of primary melanoma.
@en
type
label
Molecular profiling reveals low- and high-grade forms of primary melanoma.
@ast
Molecular profiling reveals low- and high-grade forms of primary melanoma.
@en
prefLabel
Molecular profiling reveals low- and high-grade forms of primary melanoma.
@ast
Molecular profiling reveals low- and high-grade forms of primary melanoma.
@en
P2093
P2860
P50
P1476
Molecular profiling reveals low- and high-grade forms of primary melanoma.
@en
P2093
Anna Karlsson
Anna Måsbäck
Christian Ingvar
Göran Jönsson
Henrik Ekedahl
Hensin Tsao
Iva Johansson
Johan Staaf
Jürgen Geisler
Katja Harbst
P2860
P304
P356
10.1158/1078-0432.CCR-12-0343
P407
P577
2012-06-06T00:00:00Z